Disparities in PI3K/mTOR inhibitor use, toxicities, and outcomes among patients with metastatic breast cancer

Claire Sathe, Melissa K. Accordino, David DeStephano, Mansi Shah, Jason D. Wright, Dawn L. Hershman

Producción científica › revisión exhaustiva

1 Cita (Scopus)

Huella

Profundice en los temas de investigación de 'Disparities in PI3K/mTOR inhibitor use, toxicities, and outcomes among patients with metastatic breast cancer'. En conjunto forman una huella única.

Pharmacology, Toxicology and Pharmaceutical Science